Zydus Lifesciences Ltd.

In accordance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 and based on the certificate received from Link lntime India (RTA), Cadila Healthcare has confirmed that for the quarter ended on December 31, 2021, the certificates of equity shares received for dematerialization have been mutilated and cancelled only after due verification and that the name of the respective depository has been substituted as the registered owner in respect of those dematerialized equity shares. Further, it confirmed that the securities comprised in the said certificates of equity shares have been listed on BSE and the National Stock Exchange of India where the earlier issued securities are listed.

The above information is a part of company’s filings submitted to BSE.